Table 2.
Prevalence of Blastocystis sp. in the CRC and control groups determined by LM and PCR
| Parameter | LM | PCR | ||||
|---|---|---|---|---|---|---|
| Patients with CRC n = 107 |
Control group n = 124 |
p | Patients with CRC n = 95 |
Control group n = 76 |
p | |
| Age, years: | ||||||
| Median (range) | 65 (38–88) | 63 (38–88) | 0.17a | 66 (40–88) | 64 (38–88) | 0.71a |
| Sex, number (%) | ||||||
| Women | 41 (38.3%) | 55 (44.3%) | 0.42b | 37% | 26% | 0.63b |
| Men | 66 (61.7%) | 69 (55.7%) | 58% | 50% | ||
| Blastocystis sp. infection, patients (%) | ||||||
| Present | 13 (12.15%) | 3 (2.42%) | 0.0041b | 12 (12.63%) | 2 (2.63%) | 0.02 |
| Absent | 94 (87.85%) | 121 (97.58%) | 83 (87.37%) | 74 (97.37%) | 3b | |
aMann–Whitney U test
bFisher’s exact test